Private company · employee equity guide

OOpenEvidence logo

What is OpenEvidence stock worth?

Launched during the Mayo Clinic Platform Accelerate program, backed by Sequoia and Google, and an official Content Partner of the New England Journal of Medicine and The Journal of the American Medical Association OpenEvidence is the world’s leading medical information platform.

Estimated share price

Members onlySee the real chart, freeNo card. Takes about a minute.

OpenEvidence has an observed estimated price: most recent data 2026-09-15, daily history back to 2025-06-28.

Estimated from live trades and accepted bids across employer liquidity programs, institutional trades, broker trades, and pre-IPO marketplaces. Private shares are illiquid and transfer-restricted; estimates are educational, not an offer or advice. The preview above is blurred and illustrative. How this is calculated

About OpenEvidence

Employees
129
Founded
2021
Industry
Software Development, Technology, Information and Internet, Technology, Information and Media
Website
openevidence.com

Weighing a OpenEvidence offer?

Upload the offer letter to see what the equity is approximately worth at today's estimated price. No account needed.

X-ray an offer

Leaving OpenEvidence? Mind the window.

If you hold options, leaving usually starts a post-termination exercise clock, often 90 days. Miss it and vested options can expire worthless; exercise blindly and you may owe real money (including possible AMT) on shares you can't yet sell. Neither panic nor autopilot is a plan. Knowing your window, your exercise cost, and the current estimated price is.

Track my window freeUpload your grant doc. We extract the window and set the reminders.

OpenEvidence in the last 12 months

  • 2 funding round

Covered by 21 distinct publications since 2023-07-27.

Who founded OpenEvidence

Daniel Nadler

OpenEvidence news timeline

OpenEvidence equity, answered plainly

Is OpenEvidence a public company?

No. OpenEvidence is privately held, which is exactly why its share price doesn't show up in your brokerage app. The company (founded in 2021, operating in software development, with roughly 129 employees) remains private even at that scale. Its shares still change hands between eligible buyers and sellers on the secondary market, producing an observable estimated price.

What is OpenEvidence's stock price?

OpenEvidence has an observed estimated share price from secondary-market activity, updated as new data is observed. Its observed price history runs back to 2025-06-28. ExitCue members see the current estimate and its full history free, along with what their own grants are approximately worth at that price.

Can you sell OpenEvidence stock before an IPO?

Sometimes. Private-share sales depend on OpenEvidence's transfer restrictions, rights of first refusal, and whether the company runs tender offers or permits secondary sales. Your grant documents and the company's policies govern, but "hard to sell today" is not the same as "worth zero."

What happens to my OpenEvidence options if I leave?

Most option grants have a post-termination exercise window, commonly 90 days, sometimes longer, after which unexercised options expire worthless. The exact terms are in your grant documents. ExitCue reads those documents, tracks the deadline, and reminds you before the window closes.

How much is my OpenEvidence equity worth?

Multiply what you hold by the estimated share price, separating vested from unvested, and netting out strike prices for options. That's precisely the arithmetic ExitCue does for you, continuously, at the current observed estimate. It's an educational estimate, not a guarantee, and a far better anchor than the $0 the internet suggests.

What's the difference between OpenEvidence's 409A valuation and what its shares trade at?

The 409A is a tax-compliance appraisal, usually conservative, used to set option strike prices. Secondary-market pricing reflects what buyers and sellers actually agree to. The two frequently differ, which is why evaluating an offer on the 409A alone undersells (or oversells) it.

When will OpenEvidence IPO?

Unless OpenEvidence has publicly announced a listing, nobody knows, including the people who sound confident on forums. The practical upside of secondary markets is that you don't have to wait for an IPO to know approximately what the shares trade at.

Do my unvested OpenEvidence RSUs count for anything?

Unvested equity isn't yours yet, but it has an estimable value and a schedule. Seeing vested and unvested value separately, in dollars at the current estimated price, turns "some RSUs" into a number you can plan around.

General educational information, not advice about your specific situation. Grant terms vary; your documents govern.

Work out what your OpenEvidence equity is worth

These calculators take your own numbers and need no account.

New to this? Learn explains grant types, vesting and cliffs, and where an estimated share price comes from — in plain language.

Other private companies with observed prices

Company logos provided by Brandfetch.